Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: January 1, 2020; Last Reviewed: August 1, 2019
||Emory University||National Institutes of Health||Research Support|
|Crothers, Kristina*||University of Washington||American Lung Association||Research Support|
|National Institutes of Health||Research Support|
|Kobayashi, Miwako||Centers for Disease Control and Prevention||None||N/A|
|Matanock, Almea||Centers for Disease Control and Prevention||Gavi, The Vaccine Alliance||Research Support|
|Miller, Robert||University College London, England||Gilead||Honoraria, Speaker’s Bureau|
|British HIV Association||Research Support|
|Niederman, Michael||Cornell University||Bayer||Advisory Board, Research Support|
|Merck||Advisory Board, Research Support|
|Shionogi||Advisory Board, Research Support|
|Rodriguez-Barradas, Maria||Michael E. DeBakey VAMC and Baylor College of Medicine||None||N/A|
* Group lead
Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive